Journals / Haseki Tıp Bülteni / 2001 / Cilt: 39 - Sayı: 3

Effects of acarbose on serum potassium levels in type 2 diabetes mellitus patients

Tip II diyabetik hastalarda akarboz kullanımının serum potasyum değerlerine etkisi

Pages
209–212
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Difference was istatisticaly meaningful (p < 0.05)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study; we compared the pretreatment and posttreatment serum potassium levels of the type 2 diabetic patients using oral antidiabetic (OAD) and OAD + acarbose.
📊
Key Findings & Data:For this, type 2 diabetic patients that they were using only OAD and 16 type 2 diabetic patients that they were using OAD + acarbose were followed in the diabet outpatient At initial and after 3 months later; serum potassium levels were controlled. 3 months later after therapy; the serum potassium levels of the group using acarbose were found much lower.
💡
Conclusion & Impact:Difference was istatisticaly meaningful (p < 0.05)
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diabetes mellitus · insülin bağımsız · Elektrokardiyografi

Abstract

In this study; we compared the pretreatment and posttreatment serum potassium levels of the type 2 diabetic patients using oral antidiabetic (OAD) and OAD + acarbose. For this, type 2 diabetic patients that they were using only OAD and 16 type 2 diabetic patients that they were using OAD + acarbose were followed in the diabet outpatient At initial and after 3 months later; serum potassium levels were controlled. 3 months later after therapy; the serum potassium levels of the group using acarbose were found much lower. Difference was istatisticaly meaningful (p < 0.05)

Özet

Bu çalışmada OAD ve OAD+akarboz kullanan tip II diabetik hastaların tedavi öncesi ve tedavi sonrası serum potasyum düzeylerini karşılaştırdık. Bu amaçla yalnız oral antidiyabetik (OAD) kullanan 20 tip n diabetik hasta ve OAD ile birlikte akarboz kullanan 20 tip II diyabetik hasta, diyabet polikliniğimizden takibe alındı. Başlangıç ve 3 ay sonraki serum potasyum değerleri ve EKG bulguları kontrol edildi. 3 aylık tedavi sonrasında akarboz kullanan grubun serum potasyum düzeyleri daha düşük bulundu. Fark istatistiki olarak anlamlıydı (p<0.05).

🔖

Cite This Article

TEMİZ, L. Ü., ŞAR, F., KOLDAŞ, M., AYER, M., ATAOĞLU, E., YENİGÜN, M. (2001). Effects of acarbose on serum potassium levels in type 2 diabetes mellitus patients. Haseki Tıp Bülteni, Cilt: 39 - Sayı: 3, 209–212. https://ajindex.com/articles/268085